PMED — Peptonic Medical AB Income Statement
0.000.00%
Last trade - 00:00
- SEK22.72m
- SEK15.14m
- SEK37.12m
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | Interim Report | ARS | ARS | PRESS |
Standards: | — | — | SAS | SAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4.41 | 35.2 | 31.6 | 43.6 | 37.1 |
Cost of Revenue | |||||
Gross Profit | 2.58 | 21.1 | 19.1 | 23.4 | 16.3 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 28.3 | 68.2 | 105 | 77.2 | 78.3 |
Operating Profit | -23.9 | -33 | -73.7 | -33.6 | -41.2 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -24.5 | -34.2 | -73.7 | -36.9 | -42.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -24.5 | -34.2 | -73.7 | -36.9 | -42.6 |
Net Income Before Extraordinary Items | |||||
Net Income | -24.5 | -34.2 | -73.7 | -36.9 | -42.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -24.5 | -34.2 | -73.7 | -36.9 | -42.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.104 | -0.112 | -0.16 | -0.093 | -0.036 |
Dividends per Share |